Abstract: A mode register control circuit may include a masking signal generation circuit and a storage control pulse generation circuit. The masking signal generation circuit may be configured to generate a masking signal from data. The storage control pulse generation circuit may be configured to generate a storage control pulse for controlling a mode register write operation, from a mode register write pulse in response to the masking signal.

Abstract: The present invention relates to a honeybee pollen composition, and more particularly to a honeybee pollen composition prepared by mixing solidified honeybee pollen with distilled water and an admixture consisting of a dispersant, a preservative, a thickener, an antioxidant, or a neutralizer and then performing pulverization with a particle size of 100 to 500 nm, resulting in an efficient disruption of cell walls of the honeybee pollen and making the composition into a formulation available for easier ingestion in the body or skin, where the admixture, including a dispersant, a preservative, a thickener, an antioxidant, a neutralizer, etc., is added to the solidified honeybee pollen in the pulverization process to increase the stability, antioxidant effects and polyphenol content of the honeybee pollen composition, thereby acquiring availability of the composition as a cosmetic material or a pharmaceutical composition.

Abstract: The invention provides methods and systems for detecting a biomarker in a synovial fluid wherein the system also includes a control to ensure that the test sample is indeed synovial fluid. The biomarkers and the control for synovial fluid can be identified using proteomic methods, including but not limited to antibody based methods, such as an enzyme-linked immunosorbant assay (ELISA), a radioimmunoassay (RIA), or a lateral flow immunoassay.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter Syndrome.

Abstract: The invention provides methods and systems for detecting a biomarker in a synovial fluid wherein the system also includes a control to ensure that the test sample is indeed synovial fluid. The biomarkers and the control for synovial fluid can be identified using proteomic methods, including but not limited to antibody based methods, such as an enzyme-linked immunosorbant assay (ELISA), a radioimmunoassay (RIA), or a lateral flow immunoassay.

Abstract: A circuit for setting a reference voltage is provided. The circuit includes a reference voltage information storage unit and a reference voltage input/output (I/O) control unit. The reference voltage information storage unit is configured to set a level of a reference voltage according to information stored in a first register or a second register if a training operation starts in a first set mode. The reference voltage I/O control unit is configured to set a level of the reference voltage according to first data or second data if the training operation starts in a second set mode.

Abstract: A semiconductor system may include: an external channel including a CA (Command/Address) channel, and first and second data channels; and first and second semiconductor chips, which are coupled in common to the CA channel and coupled to respective different ones of the first and second data channels, and each of which includes a coupling information pad. A first value may be inputted to the coupling information pad of one of the first and second semiconductor chips that is coupled to the first data channel, and a second value may be inputted to the coupling information pad of the other semiconductor chip that is coupled to the second data channel. Each of the first and second semiconductor chips selectively stores setting information using CA information applied to the CA channel and a value inputted to the corresponding coupling information pad.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter Syndrome.

Abstract: A semiconductor system may include: an external channel including a CA (Command/Address) channel, and first and second data channels; and first and second semiconductor chips, which are coupled in common to the CA channel and coupled to respective different ones of the first and second data channels, and each of which includes a coupling information pad. A first value may be inputted to the coupling information pad of one of the first and second semiconductor chips that is coupled to the first data channel, and a second value may be inputted to the coupling information pad of the other semiconductor chip that is coupled to the second data channel. Each of the first and second semiconductor chips selectively stores setting information using CA information applied to the CA channel and a value inputted to the corresponding coupling information pad.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: A circuit for setting a reference voltage is provided. The circuit includes a reference voltage information storage unit and a reference voltage input/output (I/O) control unit. The reference voltage information storage unit is configured to set a level of a reference voltage according to information stored in a first register or a second register if a training operation starts in a first set mode. The reference voltage I/O control unit is configured to set a level of the reference voltage according to first data or second data if the training operation starts in a second set mode.

Abstract: A circuit for setting a reference voltage is provided. The circuit includes a reference voltage information storage unit and a reference voltage input/output (I/O) control unit. The reference voltage information storage unit is configured to set a level of a reference voltage according to information stored in a first register or a second register if a training operation starts in a first set mode. The reference voltage I/O control unit is configured to set a level of the reference voltage according to first data or second data if the training operation starts in a second set mode.

Abstract: A semiconductor system may include a first semiconductor device and a second semiconductor device. The first semiconductor device may output set signals. The second semiconductor device may generate a start signal in response to the set signals, generate an input control code and an output control code from the set signals in response to the start signal, generate a frequency determination signal including information on an operation frequency in response to the output control code, and control an internal operation in response to the frequency determination signal.

Abstract: A circuit for setting a reference voltage is provided. The circuit includes a reference voltage information storage unit and a reference voltage input/output (I/O) control unit. The reference voltage information storage unit is configured to set a level of a reference voltage according to information stored in a first register or a second register if a training operation starts in a first set mode. The reference voltage I/O control unit is configured to set a level of the reference voltage according to first data or second data if the training operation starts in a second set mode.

Abstract: A semiconductor device may include a first channel provided in a first die. The semiconductor device may include a second channel provided in a second die and disposed adjacent to the first channel, and configured to exchange signals and data with the first channel. The first channel and the second channel may receive and output calibration-related signals from and to each other through bonding, and may share calibration start signals. The calibration start signal may be respectively generated in the first channel and the second channel.

Abstract: A semiconductor system may include a first semiconductor device and a second semiconductor device. The first semiconductor device may output set signals. The second semiconductor device may generate a start signal in response to the set signals, generate an input control code and an output control code from the set signals in response to the start signal, generate a frequency determination signal including information on an operation frequency in response to the output control code, and control an internal operation in response to the frequency determination signal.

Abstract: A semiconductor device may include a first channel provided in a first die. The semiconductor device may include a second channel provided in a second die and disposed adjacent to the first channel, and configured to exchange signals and data with the first channel. The first channel and the second channel may receive and output calibration-related signals from and to each other through bonding, and may share calibration start signals. The calibration start signal may be respectively generated in the first channel and the second channel.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: A semiconductor system includes a controller and a semiconductor device. The controller generates a clock signal and updates external count signals in response to an external update signal. The semiconductor device generates count signals by counting pulses of a strobe signal during a period when a section signal is in an active state. The section signal is generated in response to a first control signal including pulses that are periodically generated. The semiconductor device also generates the external update signal and the external count signals if a combination of the count signals is changed.

Abstract: A semiconductor device may include a first channel provided in a first die. The semiconductor device may include a second channel provided in a second die and disposed adjacent to the first channel, and configured to exchange signals and data with the first channel. The first channel and the second channel may receive and output calibration-related signals from and to each other through bonding, and may share calibration start signals. The calibration start signal may be respectively generated in the first channel and the second channel.